BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6634416)

  • 1. [Results of radioiodine treatment of autonomous thyroid adenomas taking into consideration regional iodine kinetics and paranodular uptake].
    Tosch U; Moser E; Büll U
    Nuklearmedizin; 1983 Aug; 22(4):187-91. PubMed ID: 6634416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of radioiodine therapy in different forms of hyperthyroidism in relation to the planned dosage].
    Moser E
    Aktuelle Radiol; 1992 Jul; 2(4):179-87. PubMed ID: 1504115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine.
    Huysmans DA; Corstens FH; Kloppenborg PW
    J Nucl Med; 1991 Jan; 32(1):27-30. PubMed ID: 1988632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iodine-131 therapy of autonomous adenoma of the thyroid. 7-year results].
    Heinze HG; Bohn U
    Dtsch Med Wochenschr; 1987 Jul; 112(27):1073-9. PubMed ID: 3595467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses].
    Moser E; Pickardt CR; Mann K; Engelhardt D; Kirsch CM; Knesewitsch P; Tatsch K; Kreisig T; Kurz C; Saller B
    Nuklearmedizin; 1988 Jun; 27(3):98-104. PubMed ID: 3405782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thyroid function following radioiodine resection of autonomous thyroid adenomas].
    Heinze HG; Pickardt CR; Swoboda G; Horn K; Erhardt F; Scriba PC
    Nuklearmedizin; 1977 Oct; 16(5):224-31. PubMed ID: 593905
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up of solitary autonomous thyroid nodules treated with 131I.
    Goldstein R; Hart IR
    N Engl J Med; 1983 Dec; 309(24):1473-6. PubMed ID: 6646172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results following surgery or radioiodine treatment of solitary autonomous adenoma of the thyroid gland].
    Müller-Gärtner HW; Schneider C; Riechert B; Kayser D; Kremer B
    Chirurg; 1989 Jan; 60(1):33-7. PubMed ID: 2493360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction of thyroid volume following radioiodine therapy for functional autonomy].
    Luster M; Jacob M; Thelen MH; Michalowski U; Deutsch U; Reiners C
    Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the thyroid technetium-99m scintigram after antithyroid and subsequent radioiodine treatment for solitary autonomous nodules.
    Nygaard B
    Thyroid; 1998 Mar; 8(3):223-7. PubMed ID: 9545108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autonomous adenoma of the thyroid gland and radioiodine therapy].
    Kuchar O; Kraft O
    Vnitr Lek; 1987 Sep; 33(9):739-47. PubMed ID: 3672952
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D; Epstein M; Lan L; Tan P; Booker J
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radio-iodine therapy of toxic adenoma of the thyroid (author's transl)].
    Heinze HG; Pfeifer KJ; Lichtenstein Z
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2203-8. PubMed ID: 1175469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I.
    Menzel C; Kranert WT; Döbert N; Diehl M; Fietz T; Hamscho N; Berner U; Grünwald F
    J Nucl Med; 2003 Jul; 44(7):1065-8. PubMed ID: 12843221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioiodine therapy of toxic adenomas of the thyroid gland].
    Kinser J; Rösler H
    Ther Umsch; 1973 Oct; 30(10):726-33. PubMed ID: 4745946
    [No Abstract]   [Full Text] [Related]  

  • 18. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with radioiodine in multiple autonomous adenomas of thyroid gland].
    Frey KW; Heinze HG; Kolb E
    Fortschr Geb Rontgenstr Nuklearmed; 1968 May; 108(5):586-96. PubMed ID: 5748679
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
    Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
    Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.